Thank you
Thank you for your interest in HUMIRA. We appreciate the opportunity to help you learn more about non-infectious uveitis.* Be on the lookout for information coming to your mailbox soon.
In the meantime, learn more about HUMIRA for non-infectious intermediate, posterior, and panuveitis.*
*HUMIRA (adalimumab) is approved for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
US-HUMU-180357
